A doctor sits with Tram Mai to discuss what we should know about GLP-1 drugs and their side effects. McDonald's CEO prepares ...

The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

GLP-1s are changing the menu landscape for restaurants as diners fundamentally change how they eat. Here's what you'll start ...

GI side effects from GLP-1s may cause patients to drop the medications or turn to OTC remedies. Gastroenterologists don’t ...

Combining GLP-1 medications with 8 healthy lifestyle habits reduced the risk of major adverse cardiovascular events, or MACE, ...

By Amina Niasse NEW YORK, March 2 (Reuters) - Telehealth company Hims & Hers Health, known for its weight-loss drug business, ...

A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and ...

Consumer health advertising is driving many employees to take action on GLP-1s. But without guidance, those decisions could be risky.

GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, expanding to cardiovascular and neurodegenerative disorders. Innovations like oral ...

GLP‑1 drugs are reshaping appetite, cravings and taste perception. Discover new research and what it means for food and drink ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...